Source comparison
NAD+ Precursor Comparison Table (2026 Research Focus)
Primary Pathway Salvage Pathway Direct Cellular Uptake Typical Oral Dose 250-1000 mg/day 100-1000 mg/day N/A (not oral) Bioavailability Good (Oral) Excellent (Direct) Speed of Action Moderate Rapid Research Focus Longevity, Metabolism, Cognition Longevity, DNA
This comparison does not assign a generated winner or score.
- Primary Pathway
- Salvage Pathway
- Direct Cellular Uptake
- Typical Oral Dose
- 250-1000 mg/day
- 100-1000 mg/day
- N/A (not oral)
- Bioavailability
- Good (Oral)
- Excellent (Direct)
- Speed of Action
- Moderate
- Rapid
- Research Focus
- Longevity, Metabolism, Cognition
- Longevity, DNA Repair, Metabolism
- Acute Cellular Response, Energy
- Cost (Relative)
- Moderate to High
- High
- Key Advantage
- Well-studied, fewer side effects
- Potent, direct NAD+ precursor
- Max bioavailability, precision
- This comparison table, informed by 2026 research trends, helps illustrate why an informed NAD+ dosage guide needs to account for the specific characteristics of each compound. Each option brings its own set of advantages and considerations to the research bench.
- When it comes to advancing cellular health and longevity research, precision and purity are everything. Our team at Real Peptides is dedicated to providing the highest quality research compounds, ensuring your studies are built on a foundation of reliability. We encourage you to continue exploring the vast potential of NAD+ and its precursors, always with an eye toward rigorous methodology and exceptional product quality. For all your research needs, we're here to help you Find the Right Peptide Tools for Your Lab.